Literature DB >> 35554748

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow's node metastasis.

Yoshihiro Hara1, Kenichi Nakamura1, Shiro Iwagami1, Katsuhiro Ogawa1, Hiroshi Sawayama1, Masaaki Iwatsuki1, Yoshifumi Baba1, Yuji Miyamoto1, Naoya Yoshida1, Hideo Baba2.   

Abstract

BACKGROUND: Gastric cancer is relatively prone to metastasis, although distant metastasis is rare during the early stage of disease. Here we report a rare case of schwannoma-associated Virchow metastasis of a patient with early-stage gastric cancer. CASE
PRESENTATION: A 73-year-old man, diagnosed with early-stage gastric cancer, underwent preoperative scrutiny, and was only suspected to have Virchow metastasis. Owing to atypical metastatic findings, a lymph node biopsy was performed to confirm the diagnosis and to determine the treatment strategy. The pathology results of the biopsy showed a diagnosis of schwannoma, the patient was judged to be surgically resectable, and a laparoscopic gastrectomy was performed to achieve a radical resection. The patient is currently under outpatient observation with no apparent recurrence.
CONCLUSION: Systemic chemotherapy is generally administered according to the physician's clinical judgment, although the results of a lymph node biopsy contribute to a more curative treatment. When nonspecific metastases are found, it is important to make a reliable diagnosis and to select a treatment that achieves a cure.
© 2022. The Author(s).

Entities:  

Keywords:  Gastrectomy; Gastric cancer; Schwannoma; Virchow metastasis

Year:  2022        PMID: 35554748      PMCID: PMC9106788          DOI: 10.1186/s40792-022-01439-0

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


Background

Gastric cancer is relatively prone to metastasis, and Virchow metastasis is one of the most common types of distant metastases that target the lymphatics. Other metastases are hematogenous liver metastasis, disseminated Schnitzler metastasis, and Krukenberg metastasis, which may be caused by multiple factors. Although such distant metastases are often found in advanced cancers according to their depth of invasion or presence in lymph nodes, certain cases of gastric cancer with distant metastases occur during the early stage of disease [1, 2]. Here we report a case of clinical stage-I gastric cancer with a schwannoma on the left supraclavicular fossa, which was suspected as Virchow’s node metastasis.

Case presentation

A 73-year-old man presented with a sore throat, hoarseness, and weight loss. Upper gastrointestinal endoscopy revealed a 30-mm type 0-IIc lesion on the posterior wall of the cardia of the stomach with an estimated depth of the muscularis propria (T2). (Fig. 1). An upper gastrointestinal series showed deformation of the posterior wall of the cardia, suggesting infiltration of the lesion into the muscularis propria (T2).
Fig. 1

Upper gastrointestinal endoscopy

Upper gastrointestinal endoscopy Biopsy showed a poorly differentiated adenocarcinoma with signet-ring cells. Contrast-enhanced computed tomography (CT) showed an enlarged lymph node in the left subclavian region, and a positron emission tomography-CT (PET-CT) scan showed mild FDG accumulation in the same lymph node (SUV-max3.7), which was suspected as a Virchow metastasis. (Figs. 2, 3).
Fig. 2

CT

Fig. 3

PET-CT

CT PET-CT There were no other obvious lymph node or distant metastasis findings. The cervical lymph nodes were not palpable, and blood tests detected normal levels of tumor markers and other variables (Table 1).
Table 1

Preoperative blood analysis

Variable (unit)ValueVariable (unit)ValueVariable (unit)Value
WBC (× 103/ml)3.0Alb (g/dl)4.8Na (mEq/l)140
RBC (× 106/ml)4.30BUN (mg/dl)14.2K (mEq/l)4.1
Hb (g/dl)13.9Crea (mg/dl)0.79Cl (mEq/l)103
Hct (%)40.0S-Glu (mg/dl)99Amy (U/l)105
PLT(× 103/µl)192T-Bil (mg/dl)1.1Ca (mg/dl)9.3
Neut (%)53.2T-Bil (mg/dl)0.1CK (U/l)84
Lymp (%)38.5AST (U/l)26CRP (mg/dl)0.01
Mono (%)6.3ALT (U/l)18
PT (%)120LD (U/l)241AFP3.8
APTT (%)102γ-GTP (U/l)17CEA1.7
P-FDP (µg/ml)4.5ALP (U/l)173CA19-9 < 0.6
D-dimer (µg/ml)1.7CHE (U/l)222STN38.0
TP (g/dl)7.4

γ-GTP1 γ-glutamyltransferase, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, Amy amylase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, BE base excess, BUN blood urea nitrogen, Ca calcium, CHE cholinesterase, CK creatine kinase, Cl chloride, Crea creatinine, CRP C-reactive protein, D-dimer d-dimer, Hb hemoglobin, Hct hematocrit, K potassium, LD lactate dehydrogenase, Lym lymphocyte, Mono monocyte, Na sodium, Neu neutrophil, P-FDP plasma–fibrin–fibrinogen degradation product, PT prothrombin time, S-Glu serum glucose, T-Bil total bilirubin, D-Bil direct bilirubin, TP total protein, WBC white blood cell, AFP alpha-fetoprotein, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, STN sialyl Tn antigen

Preoperative blood analysis γ-GTP1 γ-glutamyltransferase, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, Amy amylase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, BE base excess, BUN blood urea nitrogen, Ca calcium, CHE cholinesterase, CK creatine kinase, Cl chloride, Crea creatinine, CRP C-reactive protein, D-dimer d-dimer, Hb hemoglobin, Hct hematocrit, K potassium, LD lactate dehydrogenase, Lym lymphocyte, Mono monocyte, Na sodium, Neu neutrophil, P-FDP plasma–fibrin–fibrinogen degradation product, PT prothrombin time, S-Glu serum glucose, T-Bil total bilirubin, D-Bil direct bilirubin, TP total protein, WBC white blood cell, AFP alpha-fetoprotein, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, STN sialyl Tn antigen We suspected Virchow metastasis of gastric cancer and therefore performed a left subclavian lymph node biopsy to determine the treatment strategy. Because of the close location of the cervical blood vessels and the risk of recurrent nerve injury, it was judged that a biopsy under local anesthesia would be difficult and was performed under general anesthesia. The tumor was an elastic, firm, well-defined limbed mass, approximately 20 mm major axis, located on the left side of the esophagus, dorsal to the left carotid artery and jugular vein. The tumor was completely removed. Pathological findings showed eosinophilic spindle-shaped cells that exhibited bundled and intricate arrangements. Immunostaining revealed diffuse expression of S100, which is diagnostic of a schwannoma (Fig. 4).
Fig. 4

Histological findings of cervical tumor

Histological findings of cervical tumor We, therefore, planned curative gastrectomy appropriate for the diagnosis of gastric cancer clinical stage I. One month after the biopsy, we performed laparoscopic proximal gastrectomy with D1 + dissection and double-tract reconstruction. Histopathological findings of the stomach were Type 2, por2 > tub2, pT3(SS), V1b, without detectable lymph node metastasis (pStage IIA) (Fig. 5).
Fig. 5

Gastric cancer

Gastric cancer The patient's postoperative course was good, and he began oral nutritional intake on the fourth postoperative day and was discharged on the tenth postoperative day. As of the completion of this case report (9 months after surgery), there has been no obvious recurrence, and the patient is being followed as an outpatient.

Discussion

When early-stage gastric cancer is diagnosed, lymph node metastasis is not uncommon. According to the Gastric Cancer Treatment Guidelines 2018, Japanese Gastric Cancer Association [14], early-stage gastric cancer (SM1: < 500 µm from the muscularis mucosae) generates lymph node metastasis in ≤ 10% of cases, depending on the presence of an ulcer, cellular differentiation, and size. However, most metastases involve the perigastric lymph nodes of regional lymph nodes, and distant lymph node metastases are extremely rare. Among the 6 cases of Virchow metastasis associated with early gastric cancer reported in Japan, 4 patients survived for 3 to 7 months. Among the remaining 2 cases, 1 did not have detectable regional lymph node metastasis and survived for 5 years following resection and postoperative chemotherapy. The other patient underwent distal gastrectomy with extensive lymph node dissection of the para-aortic area and received postoperative chemotherapy, which contributed to the reduction of Virchow’s node metastasis. This latter patient survived 4 months after surgery without recurrence. Although our present patient had advanced gastric cancer, we suspected only Virchow lymph node metastasis, and there were no other noncurative factors. We, therefore, considered an appropriate treatment strategy. The most frequent sites of overlapping cancers of the stomach, in decreasing order, are colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and lymphoma, although the association with schwannoma is not clear [3-8]. To the best our knowledge, the 3 published cases describe gastric cancer and sporadic schwannoma that developed in the retroperitoneum, para-aortic area, and liver [9, 11–13] (Table 2). Furthermore, Von Recklinghausen disease (neurofibromatosis), which is related to schwannoma, is frequently associated with malignancies, although rarely with gastric cancer [10].
Table 2

Patients’ characteristics

CaseAgeGenderPathological result of Gastric cancerRegion of tumorDiagnosis of tumorReporterReport yearOperation
64F(Early stage)LiverSchwannomaWada Y, (12)1998Gastrectomy and partial hepatectomy
262FT1bN0M0,-, pStageIRetroperitonealSchwannomaMatsuhashi N, (9)2013Lap-distal gastrectomy and tumor resection
374MT1bN0M0, por, pStageIPara-aortic lymph nodeSchwannomaGakuhara A, (11)2018Lap-distal gastrectomy and tumor resection
473MT3N0M0, por, pStageIIALeft subclavian lymph nodeSchwannomaOwn case2020

Lymph node biopsy

Lap-proximal gastrectomy

Lap Laparoscopic

Patients’ characteristics Lymph node biopsy Lap-proximal gastrectomy Lap Laparoscopic Schwannomas most often occur in the spinal cord, brain, limbs, neck, and rarely in the gastrointestinal tract [11]. Schwannomas mainly originate in the peripheral nerve sheath and are solitary. Generally, schwannomas are benign, although some may not be recognized as malignant tumors. Consequently, cases of recurrence and malignancies are reported, although they were actually benign, and therefore require follow-up. Gastrointestinal schwannoma, which is relatively rare, is considered a submucosal tumor that is easily treatable. Furthermore, a small number of cases of systemic diseases, such as sarcoidosis coexisting with early gastric cancer are considered difficult to distinguish from distant metastases, as in the present case [15]. Systemic chemotherapy is considered the standard treatment for distant metastasis and advanced lymph node metastasis of gastric cancer; and surgical resection, including preoperative chemotherapy, is considered an alternative. In such cases, when the primary tumor is clearly early-stage gastric cancer, other lymphadenopathies as well as metastasis must be considered. However, as in the present case, the pathological diagnosis is an advanced cancer, and diagnosis based on clinical and imaging findings alone is considered difficult. Here we suspected only Virchow metastasis. We therefore administered nonspecific, diagnostic treatment and performed a cervical lymph node biopsy, leading to the diagnosis of a curable schwannoma. Instead, if the patient was diagnosed with stage-IV gastric cancer at the time of imaging, systemic chemotherapy may have been selected vs radical treatment. Therefore, it is important to consider other comorbidities and determine the diagnosis and treatment strategy if metastases or nonspecific masses are found that are inconsistent with the progression of the primary tumor.

Conclusion

We treated a patient with a left subclavian schwannoma coexisting with gastric cancer, which made it difficult to preoperatively diagnose its progression.
  9 in total

1.  Multiple primary cancers in patients with gastric cancer.

Authors:  Chew-Wun Wu; Su-Shun Lo; Jen-Hao Chen; Mao-Chin Hsieh; Anna F Y Li; Wing-Yiu Lui
Journal:  Hepatogastroenterology       Date:  2006 May-Jun

Review 2.  Schwannoma of the liver: report of two surgical cases.

Authors:  Y Wada; A Jimi; O Nakashima; M Kojiro; T Kurohiji; K Sai
Journal:  Pathol Int       Date:  1998-08       Impact factor: 2.534

3.  Laparoscopic distal gastrectomy for gastric cancer with simultaneous resection of para-aortic schwannoma.

Authors:  Atsushi Gakuhara; Yasuhiro Miyazaki; Yukinori Kurokawa; Tsuyoshi Takahashi; Makoto Yamasaki; Tomoki Makino; Koji Tanaka; Masaaki Motoori; Yutaka Kimura; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Asian J Endosc Surg       Date:  2019-02-03

4.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

5.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.

Authors:  Masashi Ueno; Tetsuichiro Muto; Masatoshi Oya; Hirotoshi Ota; Kaoru Azekura; Toshiharu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2003-06       Impact factor: 3.402

6.  Patients with multiple primary gastric cancers tend to develop second primaries in organs other than the stomach.

Authors:  N Kaibara; M Maeta; M Ikeguchi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer.

Authors:  Shin Saito; Yoshinori Hosoya; Kazutomo Togashi; Kentaro Kurashina; Hidenori Haruta; Masanobu Hyodo; Koji Koinuma; Hisanaga Horie; Yoshikazu Yasuda; Hideo Nagai
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

8.  Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.

Authors:  Chan Kim; Hong Chon; Beodeul Kang; Kiyeol Kim; Hei-Cheul Jeung; Hyun Chung; Sung Noh; Sun Rha
Journal:  BMC Cancer       Date:  2013-08-23       Impact factor: 4.430

9.  Japanese gastric cancer treatment guidelines 2018 (5th edition).

Authors: 
Journal:  Gastric Cancer       Date:  2020-02-14       Impact factor: 7.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.